Skip to main content

Peer Review reports

From: Study protocol of a phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized rectal cancer

Original Submission
6 Dec 2021 Submitted Original manuscript
31 Mar 2022 Reviewed Reviewer Report - Eva Segelov
8 Apr 2022 Reviewed Reviewer Report
16 May 2022 Author responded Author comments - Claudia Corro'
Resubmission - Version 2
16 May 2022 Submitted Manuscript version 2
17 Jun 2022 Author responded Author comments - Claudia Corro'
Resubmission - Version 3
17 Jun 2022 Submitted Manuscript version 3
Publishing
24 Jun 2022 Editorially accepted
15 Jul 2022 Article published 10.1186/s12885-022-09820-w

You can find further information about peer review here.

Back to article page